ARTG 137751BioGlue Surgical Adhesive (BG3000 / BG3500 Series) - Surgical adhesive/sealant, animal-derived
ARTG ID: 137751 · Cryolife Medical (Australia) Company Pty Ltd · Artivion Inc · Class III · Started April 20, 2007
Good Name: Cryolife Medical (Australia) Company Pty Ltd - BioGlue Surgical Adhesive (BG3000 / BG3500 Series) - Surgical adhesive/sealant, animal-derived
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 137751
- Start Date
- April 20, 2007
- Effective Date
- May 12, 2023
- Name
- Artivion Inc
- Country
- United States of America
- Address
- 1655 Roberts Boulevard NW, Kennesaw, Georgia, 30144
BioGlue Surgical Adhesive is indicated for use as an adjunct to standard methods of surgical repair (such as sutures, staples, and/or patches) to adhere, seal, and/or reinforce soft tissue. Indicated soft tissues are cardiac, vascular, pulmonary, and dural.
Access comprehensive regulatory information for BioGlue Surgical Adhesive (BG3000 / BG3500 Series) - Surgical adhesive/sealant, animal-derived in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 137751 and sponsored by Cryolife Medical (Australia) Company Pty Ltd, manufactured by Artivion Inc in United States of America. The device registration started on April 20, 2007.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.